Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 3:00 pm Purchase |
2022-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
Rock Springs Capital Management LP | 1,795,733 4.870% |
256,919 (+16.70%) |
Filing History |
| 2023-02-14 1:34 pm Purchase |
2022-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
Eventide Asset Management, LLC | 2,057,000 5.600% |
2,057,000 (New Position) |
Filing History |
| 2023-02-10 09:34 am Unchanged |
2022-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
Flynn James E | 2,032,335 5.510% |
0 (Unchanged) |
Filing History |
| 2023-02-03 4:27 pm Purchase |
2022-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
BLACKROCK INC BLK |
2,136,677 5.800% |
2,136,677 (New Position) |
Filing History |
| 2022-12-01 11:07 am Sale |
2022-11-11 | 13D | Mirum Pharmaceuticals, Inc. MIRM |
RiverVest Venture Fund IV L.P. | 1,621,118 4.400% |
-300,000 (-15.62%) |
Filing History |
| 2022-09-12 5:23 pm Sale |
2022-09-08 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
Flynn James E | 2,032,335 5.530% |
-1,250,577 (-38.09%) |
Filing History |
| 2022-08-18 1:30 pm Sale |
2022-08-12 | 13D | Mirum Pharmaceuticals, Inc. MIRM |
Novo Holdings A/S | 1,760,000 4.800% |
-129,127 (-6.84%) |
Filing History |
| 2022-08-16 12:20 pm Purchase |
2022-08-12 | 13D | Mirum Pharmaceuticals, Inc. MIRM |
Frazier Life Sciences IX L.P. | 3,861,781 10.500% |
294,869 (+8.27%) |
Filing History |
| 2022-08-02 3:31 pm Sale |
2022-08-01 | 13D | Mirum Pharmaceuticals, Inc. MIRM |
Novo Holdings A/S | 1,889,127 5.900% |
-310,873 (-14.13%) |
Filing History |
| 2022-04-08 2:49 pm Sale |
2022-03-31 | 13D | Mirum Pharmaceuticals, Inc. MIRM |
Novo Holdings A/S | 2,200,000 6.900% |
-245,147 (-10.03%) |
Filing History |
| 2022-02-14 6:23 pm Purchase |
2021-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
Rock Springs Capital Management LP | 1,538,814 5.020% |
42,289 (+2.83%) |
Filing History |
| 2022-02-11 4:11 pm Sale |
2021-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
Flynn James E | 3,282,912 10.720% |
-166,000 (-4.81%) |
Filing History |
| 2021-10-25 06:07 am Sale |
2021-10-19 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
TAKEDA PHARMACEUTICAL CO LTD | 530,562 1.700% |
-1,328,589 (-71.46%) |
Filing History |
| 2021-08-24 4:32 pm Unchanged |
2021-08-19 | 13D | Mirum Pharmaceuticals, Inc. MIRM |
Novo Holdings A/S | 2,445,147 8.000% |
0 (Unchanged) |
Filing History |
| 2021-02-16 4:32 pm Purchase |
2020-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
Rock Springs Capital Management LP | 1,496,525 5.080% |
251,525 (+20.20%) |
Filing History |
| 2021-01-27 06:02 am Unchanged |
2020-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
TAKEDA PHARMACEUTICAL CO LTD | 1,859,151 7.200% |
0 (Unchanged) |
Filing History |
| 2020-12-22 4:01 pm Unchanged |
2020-12-17 | 13D | Mirum Pharmaceuticals, Inc. MIRM |
RiverVest Venture Fund IV L.P. | 1,921,118 6.600% |
0 (Unchanged) |
Filing History |
| 2020-12-18 4:31 pm Unchanged |
2020-12-15 | 13D | Mirum Pharmaceuticals, Inc. MIRM |
Novo Holdings A/S | 2,445,147 8.400% |
0 (Unchanged) |
Filing History |
| 2020-12-18 12:40 pm Unchanged |
2020-12-17 | 13D | Mirum Pharmaceuticals, Inc. MIRM |
Frazier Life Sciences IX L.P. | 3,566,912 12.200% |
0 (Unchanged) |
Filing History |
| 2020-04-29 4:36 pm Unchanged |
2020-01-13 | 13D | Mirum Pharmaceuticals, Inc. MIRM |
Frazier Life Sciences IX L.P. | 3,566,912 14.000% |
0 (Unchanged) |
Filing History |